IDXX | tickerfilter.com

Fundamental analysis

56%

Profitability 81%

Dept financing 25%

Liquidity 5%

Performance 52%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-4.68%

1 Month

-6.98%

3 Months

-15.16%

6 Months

-23.89%

1 Year

4.87%

2 Year

6.14%

Key data

Stock price

$533.92

P/E Ratio

40.85

DAY RANGE

$532.98 - $543.38

EPS

$13.69

52 WEEK RANGE

$496.61 - $769.98

52 WEEK CHANGE

$4.81

MARKET CAP

44.740 B

YIELD

N/A

SHARES OUTSTANDING

78.883 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

08-04-2025

BETA

0.89

PUBLIC FLOAT

AVERAGE 10 VOLUME

$683,248

AVERAGE 30 VOLUME

$583,715

Company detail

CEO: Jonathan J. Mazelsky
Region: US
Website: idexx.com
Employees: 10,800
IPO year: 1991

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Sector: Manufacturing

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for companion animal veterinary, livestock and poultry, dairy, and water testing markets. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides veterinary diagnostic products, including instruments, consumables, and rapid assay test kits.

IDXX - IDEXX LABORATORIES INC /DE